Shanghai Wibson Biotechnology WBS
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP antagonist) from Shanghai Wibson Biotechnology WBS between 9 Jun 2025 and 6 Aug 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Shanghai Wibson Biotechnology WBS
Tirzepatide
Tested 3 Samples
Last test 6 Aug 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Shanghai Wibson Biotechnology WBS
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
6 Aug 2025
First
9 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 Aug 2025 | View | 30mg | 33.850mg | +12.8% | 99.89% | (no batch ID) | No Label / Silver Crimp / Orange Cap | Lab F | Public | |
| 8 Jul 2025 | View | 30mg | 34.820mg | +16.1% | 99.98% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab A | Public | |
| 9 Jun 2025 | View | 15mg | 14.000mg | -6.7% | 99.22% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |